Articles from BIOTECH Patent News (November 1, 2003)

Title	Author	Type	Words
Agency of Industrial Science and Technology obtains United States patent.		Brief Article	48
Angiotech partner announces decision denying preliminary injunction.		Brief Article	144
Angiotech to acquire STS Biopolymers.			602
Antares Pharma Announces Notice of Allowance.			341
Aventis and Vertex discontinue arthritis drug trial.			716
Aventis obtains United States patent.		Brief Article	34
Boston Scientific issues copy of Court decision on stents.			348
Consejos Superior de Investigaciones Cientificas obtains United States patent.		Brief Article	164
Cornell obtains United States patent.		Brief Article	145
Eisai obtains United States patent.		Brief Article	74
Gen-Probe acquires prostate cancer test from DiagnoCure.			1100
Genaera Announces Patent Issued for Interleukin-9 Receptor.		Brief Article	166
Genaera announces patent issued protecting interleukin-9.		Brief Article	225
Genaera obtains United States patent.		Brief Article	108
Genetic Technologies settles genetics patent lawsuits with Covance and Nuvelo.		Brief Article	257
Geneva prevails court upholds Augmentin patents' invalidation.			458
GenVec obtains United States patent.		Brief Article	141
Hoffmann-La Roche $1 billion lawsuit filed by Promega.			439
Idun granted key patents in programmed cell death.			403
In the United States District Court for the District of Delaware.			1981
Innovative Biosensors licenses biosensor technology from MIT.			367
Integrated Biosystems expands cryopreservation patent portfolio.			490
Introgen patent on p53 therapy affirmed in Europe.			337
Korea Kumho Petrochemical obtains United States patent.		Brief Article	140
Korea Research Institute obtains United States patent.		Brief Article	75
Lenee, et al. obtains United States patent.		Brief Article	105
Lexicon discovers gene to control high blood pressure.			709
Momenta and Sandoz form complex pharmaceuticals strategic alliance.			477
Mount Sinai obtains United States patent.		Brief Article	135
Oncolytics Biotech granted Ras targeted herpes virus patent.		Brief Article	242
Peplin acquires portfolio of potential therapeutic products.			522
Reliant acquires Abbott's antiarrhythmic.			709
Sloan Kettering obtains United States patent.		Brief Article	65
University of Iowa obtains United States patent.		Brief Article	178
Vertex secures hepatitis C license agreement.			448
Viragen signs agreement with Pentafarma.			945
XOMA obtains United States patent.		Brief Article	139
Zyomyx strengthens biochip patent estate.		Brief Article	160